Hunan HuaTeng Pharmaceutical Co., Ltd.

Hunan Huateng Pharmaceutical Co., Ltd, founded in 2013, is a world-leading supplier of PEG derivatives and CDMO for APls and intermediates from R&D lab supply to commercial production. We provide comprehensive support for bio-pharmaceutical industry with our PEGs technology. And we also provide tailor made raw materials solutions for the chemical pharmaceutical industry with our state-of-the-art CDMO capabilities. Today, Huateng Pharma now has over 500 full-time employees, and set up a professional and efficient R&D team with more than 10 national, provincial and municipal experts. At present, Huateng Pharma has established a 5000 m2 R&D center and a 34000 m2 state-of-the-art, large-scale manufacturing site capable of gram-scale to tonne-scale production. Up to now, Huateng Pharma has developed thousands of mid- to high-end biopharmaceutical products and has been granted more than 60 patents, with another 50 patents under review. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we are an ideal partner for global clinical development. Now, we have established cooperative relationships with more than 500 pharmaceutical companies at home and abroad.